Transmissible spongiform encephalopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Agnesrinky (talk | contribs) |
||
| (23 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Transmissible spongiform encephalopathy}} | {{Transmissible spongiform encephalopathy}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{KS}} {{RAB}} | ||
'''For patient information, click [[Transmissible spongiform encephalopathy (patient information)|here]]''' | |||
{{SK}} TSE; prion diseases | {{SK}} TSE; prion diseases | ||
== [[Transmissible spongiform encephalopathy overview|Overview]] == | |||
== [[Transmissible spongiform encephalopathy historical perspective|Historical Perspective]] == | |||
== [[Transmissible spongiform encephalopathy pathophysiology|Pathophysiology]] == | |||
== [[Transmissible spongiform encephalopathy causes|Causes]] == | |||
== [[Transmissible spongiform encephalopathy differential diagnosis|Differentiating Transmissible spongiform encephalopathy from other Diseases]] == | |||
== [[Transmissible spongiform encephalopathy epidemiology and demographics|Epidemiology and Demographics]] == | |||
== [[Transmissible spongiform encephalopathy risk factors|Risk Factors]] == | |||
== [[Transmissible spongiform encephalopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | |||
==[[Major or mild neurocognitive disorder due to prion disease| Major or Mild Neurocognitive Disorder Due to Prion Disease]]== | |||
== Diagnosis == | |||
[[Transmissible spongiform encephalopathy history and symptoms|History and Symptoms]] | [[Transmissible spongiform encephalopathy physical examination|Physical Examination]] | [[Transmissible spongiform encephalopathy laboratory findings|Laboratory Findings]] | [[Transmissible spongiform encephalopathy other diagnostic studies|Other Diagnostic Studies]] | |||
== Treatment == | |||
[[Transmissible spongiform encephalopathy medical therapy|Medical Therapy]] | [[Transmissible spongiform encephalopathy primary prevention|Primary Prevention]] | [[Transmissible spongiform encephalopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Transmissible spongiform encephalopathy future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Transmissible spongiform encephalopathy case study one|Case #1]] | |||
==References== | ==References== | ||
*''This entry incorporates public domain text originally from the National Institute of Neurological Disorders and Stroke, [[National Institutes of Health]] [http://www.ninds.nih.gov/health_and_medical/disorders/tse.htm] and the [[U.S. National Library of Medicine]] [http://ghr.nlm.nih.gov/condition=priondisease]'' | *''This entry incorporates public domain text originally from the National Institute of Neurological Disorders and Stroke, [[National Institutes of Health]] [http://www.ninds.nih.gov/health_and_medical/disorders/tse.htm] and the [[U.S. National Library of Medicine]] [http://ghr.nlm.nih.gov/condition=priondisease]'' | ||
* {{cite journal | author=Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ | title=Iatrogenic Creutzfeldt-Jakob disease at the millennium | journal=Neurology | year=2000 | pages=1075-81 | volume=55 | issue=8 | id=PMID 11071481}} | * {{cite journal | author=Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ | title=Iatrogenic Creutzfeldt-Jakob disease at the millennium | journal=Neurology | year=2000 | pages=1075-81 | volume=55 | issue=8 | id=PMID 11071481}} | ||
| Line 21: | Line 47: | ||
*[http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm Neurodegenerative Disease.] | *[http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm Neurodegenerative Disease.] | ||
*[http://www.ninds.nih.gov/disorders/alpersdisease/alpersdisease.htm Neurodegenerative disease: Encephalopathy.] | *[http://www.ninds.nih.gov/disorders/alpersdisease/alpersdisease.htm Neurodegenerative disease: Encephalopathy.] | ||
*[http://www.ninds.nih.gov/news_and_events/proceedings/spastic_paraplegia.htm American Symposium] | *[http://www.ninds.nih.gov/news_and_events/proceedings/spastic_paraplegia.htm American Symposium] | ||
| Line 45: | Line 66: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
<references /> | |||
Latest revision as of 08:27, 20 July 2020
|
Transmissible spongiform encephalopathy Microchapters |
|
Differentiating Transmissible spongiform encephalopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transmissible spongiform encephalopathy On the Web |
|
American Roentgen Ray Society Images of Transmissible spongiform encephalopathy |
|
Directions to Hospitals Treating Transmissible spongiform encephalopathy |
|
Risk calculators and risk factors for Transmissible spongiform encephalopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2] Rinky Agnes Botleroo, M.B.B.S.
For patient information, click here
Synonyms and keywords: TSE; prion diseases
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Transmissible spongiform encephalopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Major or Mild Neurocognitive Disorder Due to Prion Disease
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
References
- This entry incorporates public domain text originally from the National Institute of Neurological Disorders and Stroke, National Institutes of Health [3] and the U.S. National Library of Medicine [4]
- Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ (2000). "Iatrogenic Creutzfeldt-Jakob disease at the millennium". Neurology. 55 (8): 1075–81. PMID 11071481.
- Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167–76. PMID 12849238.
- Prusiner SB (2001). "Shattuck lecture--neurodegenerative diseases and prions". N Engl J Med. 344 (20): 1516–26. PMID 11357156.
- Weissmann C (2004). "The state of the prion". Nat Rev Microbiol. 2 (11): 861–71. PMID 15494743.
External Links
- Transmissible Spongiform Encephalopathy
- Neurodegenerative Disease.
- Neurodegenerative disease: Encephalopathy.
- American Symposium
cs:Transmisivní spongiformní encefalopatie da:TSE de:Transmissible spongiforme Enzephalopathie ko:프리온 질병 simple:Prion disease